Hong Kong-listed CXO concept stocks rose in early trading, with WuXi Biologics (02269.HK) rising more than 9%, Zhaoyan Pharmaceutical (06127.HK) and WuXi AppTec (02359.HK) rising more than 4%, and Tigermed (03347.HK) rising more than 3%.

2025-03-14

Hong Kong-listed CXO concept stocks rose in early trading, with WuXi Biologics (02269.HK) rising more than 9%, Zhaoyan Pharmaceutical (06127.HK) and WuXi AppTec (02359.HK) rising more than 4%, and Tigermed (03347.HK) rising more than 3%.